Xeris Biopharma Holdings (XERS) Net Margin Growth (3y) (2023 - 2026)
Xeris Biopharma Holdings (XERS) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3,662.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -98.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,235.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 11,401.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4,252.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -404.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,806.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -987.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 3,232.00 |
| 10 | Xeris Biopharma Holdings | 1.11 Bn | 994.95 Mn | 72.55 Mn | 5,340.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,340.00 |
| Dec 31, 2025 | 5,193.00 |
| Sep 30, 2025 | 7,428.00 |
| Jun 30, 2025 | 10,078.00 |
| Mar 31, 2025 | 13,740.00 |
| Dec 31, 2024 | 22,851.00 |
| Sep 30, 2024 | 20,616.00 |
| Jun 30, 2024 | 27,773.00 |
| Mar 31, 2024 | 17,796.00 |
| Dec 31, 2023 | 27,964.00 |
| Sep 30, 2023 | 14,491.00 |